Home » Newsletters » BioWorld Asia

BioWorld Asia

July 19, 2000

View Archived Issues

Drugs For Sleep Disorders Could Follow Circadian Rhythm Finding

Zeltia Share Issue Brings In $172M On Madrid Exchange

EU Commissioners Determined To Resolve Biotech Standstill

Alizyme Plans To Raise #21M Through Public, Private Means

Other News To Note

Genomatix Completes First Pass At Promoter Sequence Analysis

French Government Launches Fund To Help Biotech Start-Ups

KS Biomedix Taking Sheep Antibody Into Human Trials

Transgene Selects 2 HGS Genes For Cardiovascular Applications

RiboTargets Gets Boost With #6M Second-Round Financing

Xenova Raises #10M In Units Offering In 'Improving' Market

French Government Confirms Its Stand On Gene Patenting

Challenges Pending For New Biotechnology Patent Rules

Biovector Plans To Move Flu Vaccine Into Phase III Trials

IBT Forced To Restructure Due To Shareholder Pressure

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...